{"id":394262,"date":"2020-12-07T08:18:09","date_gmt":"2020-12-07T13:18:09","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=394262"},"modified":"2020-12-07T08:18:09","modified_gmt":"2020-12-07T13:18:09","slug":"silo-pharma-inc-expands-scientific-advisory-board-with-appointment-of-dr-peter-hendricks-of-university-of-alabama-at-birmingham","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/silo-pharma-inc-expands-scientific-advisory-board-with-appointment-of-dr-peter-hendricks-of-university-of-alabama-at-birmingham\/","title":{"rendered":"Silo Pharma, Inc. Expands Scientific Advisory Board with Appointment of Dr. Peter Hendricks of University of Alabama at Birmingham"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">NEW JERSEY, Dec.  07, 2020  (GLOBE NEWSWIRE) &#8212; Silo Pharma, Inc. (OTCQB: SILO) a developmental stage biopharmaceutical company focused on the use of psilocybin as a therapeutic, today announced that its Board of Directors has named behavioral health expert Dr. Peter Hendricks, Ph.D. to its newly formed Scientific Advisory Board. <\/p>\n<p align=\"justify\">Dr. Peter Hendricks is an Associate Professor in the University of Alabama at Birmingham\u2019s (\u201cUAB\u201d) Health and Behavior department where he has led studies and authored a number of published research articles that explore the therapeutic impacts of psychedelic drugs, including psilocybin. UAB is one of the few universities in the world currently investigating the medicinal benefits of psilocybin.<\/p>\n<p align=\"justify\">\u201cPeter\u2019s background in drug and behavioral research strongly supplements our team as we pursue and assess new opportunities,\u201d said Eric Weisblum, CEO of Silo Pharma, Inc. \u201cOur Scientific Advisory Board is comprised of some of the most forward-thinking researchers in the industry, and will help to position Silo Pharma, Inc. as a critical player in the pursuit of ground-breaking research and innovation in the field of psychedelic medicine.\u201d<\/p>\n<p align=\"justify\">Dr. Hendricks has served as Associate Professor at UAB since 2010. He has focused his research on the interplay between psychedelic-assisted psychotherapy and a host of sociological issues such as criminality, substance abuse, and suicide. His most current area of research focused on the evaluation of the therapeutic potential of classic and novel phenethylamine, tryptamine, and lysergamide psychedelics.<\/p>\n<p align=\"justify\">\u201cSilo Pharma, Inc. will continue to support the research of commercially viable tools and drugs that seek superior outcomes for individuals suffering from emotional and behavioral disorders,\u201d added Weisblum. \u201cThe use of psychedelic drugs such as psilocybin, as an alternative therapy, have the potential to be a disruptive force in the treatment of these widespread conditions. I look forward to working with Dr. Hendricks in pursuit of opportunities in this field.\u201d \u00a0<\/p>\n<p align=\"justify\">Dr. Hendricks earned his Doctor of Philosophy from the University of South Florida in 2006. <\/p>\n<p>\n        <strong>About Silo Pharma <\/strong>\n      <\/p>\n<p align=\"justify\">Silo Pharma. Inc. is a developmental stage biopharmaceutical company focused on merging traditional therapeutics with psychedelic research for people suffering from indications such as depression, PTSD, Parkinson\u2019s, and other rare neurological disorders. Silo\u2019s mission is to identify assets to license and fund the research which we believe will be transformative to the well-being of patients and the health care industry.\u00a0 For more information, visit www.silopharma.com. <\/p>\n<p align=\"justify\">\n        <strong>Safe Harbor and Forward-Looking Statements<\/strong>\n      <\/p>\n<p align=\"justify\">This news release contains &#8220;forward-looking statements&#8221; within the meaning of the \u201csafe-harbor\u201d provisions of the Private Securities Litigation Reform Act of 1995. These statements are identified by the use of words \u201ccould\u201d, \u201cbelieve\u201d, \u201canticipate\u201d, \u201cintend\u201d, \u201cestimate\u201d, \u201cexpect\u201d, \u201cmay\u201d, \u201ccontinue\u201d, \u201cpredict\u201d, \u201cpotential\u201d and similar expressions that are intended to identify forward-looking statements. Such statements involve known and unknown risks, uncertainties and other factors that could cause the actual results of Silo Pharma, Inc. (\u201cSilo\u201d or \u201cthe Company\u201d) to differ materially from the results expressed or implied by such statements, including changes to anticipated sources of revenues, future economic and competitive conditions, difficulties in developing the Company\u2019s technology platforms, retaining and expanding the Company\u2019s customer base, fluctuations in consumer spending on the Company\u2019s products and other factors. Accordingly, although the Company believes that the expectations reflected in such forward-looking statements are reasonable, there can be no assurance that such expectations will prove to be correct. The Company disclaims any obligations to publicly update or release any revisions to the forward-looking information contained in this presentation, whether as a result of new information, future events or otherwise, after the date of this presentation or to reflect the occurrence of unanticipated events except as required by law.<\/p>\n<p align=\"justify\">\n        <b><br \/>\n          <u><br \/>\n            <b>Investor Relations Contact<\/b><br \/>\n          <\/u><br \/>\n          <b>:\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 <\/b><br \/>\n        <\/b>\n      <\/p>\n<p align=\"justify\">\n        <b><br \/>\n          <b>Hayden IR<\/b><br \/>\n        <\/b>\n      <\/p>\n<p>Brett Maas<br \/>646-536-7331<br \/>Email: brett@haydenir.com <\/p>\n<p>      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA5NzUzMiMzODU4NzEwIzUwMDA2OTMzOQ==\" width=\"1\" height=\"1\" \/><br \/>\n      <br \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/ml.globenewswire.com\/release\/track\/f4feee52-06d9-4d74-966f-6e2ffe2aa1b7\" width=\"1\" height=\"1\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>NEW JERSEY, Dec. 07, 2020 (GLOBE NEWSWIRE) &#8212; Silo Pharma, Inc. (OTCQB: SILO) a developmental stage biopharmaceutical company focused on the use of psilocybin as a therapeutic, today announced that its Board of Directors has named behavioral health expert Dr. Peter Hendricks, Ph.D. to its newly formed Scientific Advisory Board. Dr. Peter Hendricks is an Associate Professor in the University of Alabama at Birmingham\u2019s (\u201cUAB\u201d) Health and Behavior department where he has led studies and authored a number of published research articles that explore the therapeutic impacts of psychedelic drugs, including psilocybin. UAB is one of the few universities in the world currently investigating the medicinal benefits of psilocybin. \u201cPeter\u2019s background in drug and behavioral research strongly supplements our team &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/silo-pharma-inc-expands-scientific-advisory-board-with-appointment-of-dr-peter-hendricks-of-university-of-alabama-at-birmingham\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Silo Pharma, Inc. Expands Scientific Advisory Board with Appointment of Dr. Peter Hendricks of University of Alabama at Birmingham&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-394262","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Silo Pharma, Inc. Expands Scientific Advisory Board with Appointment of Dr. Peter Hendricks of University of Alabama at Birmingham - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/silo-pharma-inc-expands-scientific-advisory-board-with-appointment-of-dr-peter-hendricks-of-university-of-alabama-at-birmingham\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Silo Pharma, Inc. Expands Scientific Advisory Board with Appointment of Dr. Peter Hendricks of University of Alabama at Birmingham - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"NEW JERSEY, Dec. 07, 2020 (GLOBE NEWSWIRE) &#8212; Silo Pharma, Inc. (OTCQB: SILO) a developmental stage biopharmaceutical company focused on the use of psilocybin as a therapeutic, today announced that its Board of Directors has named behavioral health expert Dr. Peter Hendricks, Ph.D. to its newly formed Scientific Advisory Board. Dr. Peter Hendricks is an Associate Professor in the University of Alabama at Birmingham\u2019s (\u201cUAB\u201d) Health and Behavior department where he has led studies and authored a number of published research articles that explore the therapeutic impacts of psychedelic drugs, including psilocybin. UAB is one of the few universities in the world currently investigating the medicinal benefits of psilocybin. \u201cPeter\u2019s background in drug and behavioral research strongly supplements our team &hellip; Continue reading &quot;Silo Pharma, Inc. Expands Scientific Advisory Board with Appointment of Dr. Peter Hendricks of University of Alabama at Birmingham&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/silo-pharma-inc-expands-scientific-advisory-board-with-appointment-of-dr-peter-hendricks-of-university-of-alabama-at-birmingham\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2020-12-07T13:18:09+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA5NzUzMiMzODU4NzEwIzUwMDA2OTMzOQ==\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/silo-pharma-inc-expands-scientific-advisory-board-with-appointment-of-dr-peter-hendricks-of-university-of-alabama-at-birmingham\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/silo-pharma-inc-expands-scientific-advisory-board-with-appointment-of-dr-peter-hendricks-of-university-of-alabama-at-birmingham\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Silo Pharma, Inc. Expands Scientific Advisory Board with Appointment of Dr. Peter Hendricks of University of Alabama at Birmingham\",\"datePublished\":\"2020-12-07T13:18:09+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/silo-pharma-inc-expands-scientific-advisory-board-with-appointment-of-dr-peter-hendricks-of-university-of-alabama-at-birmingham\\\/\"},\"wordCount\":634,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/silo-pharma-inc-expands-scientific-advisory-board-with-appointment-of-dr-peter-hendricks-of-university-of-alabama-at-birmingham\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODA5NzUzMiMzODU4NzEwIzUwMDA2OTMzOQ==\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/silo-pharma-inc-expands-scientific-advisory-board-with-appointment-of-dr-peter-hendricks-of-university-of-alabama-at-birmingham\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/silo-pharma-inc-expands-scientific-advisory-board-with-appointment-of-dr-peter-hendricks-of-university-of-alabama-at-birmingham\\\/\",\"name\":\"Silo Pharma, Inc. Expands Scientific Advisory Board with Appointment of Dr. Peter Hendricks of University of Alabama at Birmingham - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/silo-pharma-inc-expands-scientific-advisory-board-with-appointment-of-dr-peter-hendricks-of-university-of-alabama-at-birmingham\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/silo-pharma-inc-expands-scientific-advisory-board-with-appointment-of-dr-peter-hendricks-of-university-of-alabama-at-birmingham\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODA5NzUzMiMzODU4NzEwIzUwMDA2OTMzOQ==\",\"datePublished\":\"2020-12-07T13:18:09+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/silo-pharma-inc-expands-scientific-advisory-board-with-appointment-of-dr-peter-hendricks-of-university-of-alabama-at-birmingham\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/silo-pharma-inc-expands-scientific-advisory-board-with-appointment-of-dr-peter-hendricks-of-university-of-alabama-at-birmingham\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/silo-pharma-inc-expands-scientific-advisory-board-with-appointment-of-dr-peter-hendricks-of-university-of-alabama-at-birmingham\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODA5NzUzMiMzODU4NzEwIzUwMDA2OTMzOQ==\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODA5NzUzMiMzODU4NzEwIzUwMDA2OTMzOQ==\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/silo-pharma-inc-expands-scientific-advisory-board-with-appointment-of-dr-peter-hendricks-of-university-of-alabama-at-birmingham\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Silo Pharma, Inc. Expands Scientific Advisory Board with Appointment of Dr. Peter Hendricks of University of Alabama at Birmingham\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Silo Pharma, Inc. Expands Scientific Advisory Board with Appointment of Dr. Peter Hendricks of University of Alabama at Birmingham - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/silo-pharma-inc-expands-scientific-advisory-board-with-appointment-of-dr-peter-hendricks-of-university-of-alabama-at-birmingham\/","og_locale":"en_US","og_type":"article","og_title":"Silo Pharma, Inc. Expands Scientific Advisory Board with Appointment of Dr. Peter Hendricks of University of Alabama at Birmingham - Market Newsdesk","og_description":"NEW JERSEY, Dec. 07, 2020 (GLOBE NEWSWIRE) &#8212; Silo Pharma, Inc. (OTCQB: SILO) a developmental stage biopharmaceutical company focused on the use of psilocybin as a therapeutic, today announced that its Board of Directors has named behavioral health expert Dr. Peter Hendricks, Ph.D. to its newly formed Scientific Advisory Board. Dr. Peter Hendricks is an Associate Professor in the University of Alabama at Birmingham\u2019s (\u201cUAB\u201d) Health and Behavior department where he has led studies and authored a number of published research articles that explore the therapeutic impacts of psychedelic drugs, including psilocybin. UAB is one of the few universities in the world currently investigating the medicinal benefits of psilocybin. \u201cPeter\u2019s background in drug and behavioral research strongly supplements our team &hellip; Continue reading \"Silo Pharma, Inc. Expands Scientific Advisory Board with Appointment of Dr. Peter Hendricks of University of Alabama at Birmingham\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/silo-pharma-inc-expands-scientific-advisory-board-with-appointment-of-dr-peter-hendricks-of-university-of-alabama-at-birmingham\/","og_site_name":"Market Newsdesk","article_published_time":"2020-12-07T13:18:09+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA5NzUzMiMzODU4NzEwIzUwMDA2OTMzOQ==","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/silo-pharma-inc-expands-scientific-advisory-board-with-appointment-of-dr-peter-hendricks-of-university-of-alabama-at-birmingham\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/silo-pharma-inc-expands-scientific-advisory-board-with-appointment-of-dr-peter-hendricks-of-university-of-alabama-at-birmingham\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Silo Pharma, Inc. Expands Scientific Advisory Board with Appointment of Dr. Peter Hendricks of University of Alabama at Birmingham","datePublished":"2020-12-07T13:18:09+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/silo-pharma-inc-expands-scientific-advisory-board-with-appointment-of-dr-peter-hendricks-of-university-of-alabama-at-birmingham\/"},"wordCount":634,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/silo-pharma-inc-expands-scientific-advisory-board-with-appointment-of-dr-peter-hendricks-of-university-of-alabama-at-birmingham\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA5NzUzMiMzODU4NzEwIzUwMDA2OTMzOQ==","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/silo-pharma-inc-expands-scientific-advisory-board-with-appointment-of-dr-peter-hendricks-of-university-of-alabama-at-birmingham\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/silo-pharma-inc-expands-scientific-advisory-board-with-appointment-of-dr-peter-hendricks-of-university-of-alabama-at-birmingham\/","name":"Silo Pharma, Inc. Expands Scientific Advisory Board with Appointment of Dr. Peter Hendricks of University of Alabama at Birmingham - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/silo-pharma-inc-expands-scientific-advisory-board-with-appointment-of-dr-peter-hendricks-of-university-of-alabama-at-birmingham\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/silo-pharma-inc-expands-scientific-advisory-board-with-appointment-of-dr-peter-hendricks-of-university-of-alabama-at-birmingham\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA5NzUzMiMzODU4NzEwIzUwMDA2OTMzOQ==","datePublished":"2020-12-07T13:18:09+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/silo-pharma-inc-expands-scientific-advisory-board-with-appointment-of-dr-peter-hendricks-of-university-of-alabama-at-birmingham\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/silo-pharma-inc-expands-scientific-advisory-board-with-appointment-of-dr-peter-hendricks-of-university-of-alabama-at-birmingham\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/silo-pharma-inc-expands-scientific-advisory-board-with-appointment-of-dr-peter-hendricks-of-university-of-alabama-at-birmingham\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA5NzUzMiMzODU4NzEwIzUwMDA2OTMzOQ==","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA5NzUzMiMzODU4NzEwIzUwMDA2OTMzOQ=="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/silo-pharma-inc-expands-scientific-advisory-board-with-appointment-of-dr-peter-hendricks-of-university-of-alabama-at-birmingham\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Silo Pharma, Inc. Expands Scientific Advisory Board with Appointment of Dr. Peter Hendricks of University of Alabama at Birmingham"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/394262","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=394262"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/394262\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=394262"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=394262"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=394262"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}